FSD Pharma Inc | PotStockNews

FSD Pharma Congratulates High Tide for Its Listing and Commencement of Trading on the CSE

CSE: HUGE OTCQB: FSDDF FRA: 0K9 TORONTO, Dec. 17, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) would like to congratulate High Tide Inc. ("High Tide") for its listing approval and ... [Read]

FSD Pharma Featured in CannaInvestor Magazine December Issue

Dec 12

TORONTO, Dec. 12, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) today announced that it is the featured company in the CannaInvestor Magazine December 2018 Issue. CannaInvestor Magazine is the leading industry investment magazine for cannabis ... [Read]

FSD Pharma Achieves Over 4 Billion Shares Traded in First 6 Months

Dec 3

CSE:HUGE OTCQB:FSDDF FRA: 0K9 TORONTO, Dec. 3, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) announced today that the Company has traded over four Billion Class B subordinate voting shares in its ... [Read]

FSD Pharma Reports Positive Q3 Results

Nov 30

CSE: HUGE OTCQB: FSDDF FRA: 0K9 TORONTO, Nov. 30, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) today reported its financial and operational results for the third quarter of fiscal ... [Read]

FSD Pharma and SciCann Therapeutics to present at the iCDP Summit in Boston

Nov 29

CSE: HUGE OTCQB: FSDDF FRA: 0K9 TORONTO, Nov. 29, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) announced today that Dr. Zohar Koren, CEO of its Strategic Partner SciCann Therapeutics ("SciCann") and Head of ... [Read]

FSD Pharma Facility Valued at $105,000,000 with 3,000,000 ft Expansion Assessed at $420,000,000

Nov 28

Syndicated under license via QuoteMedia CSE: HUGE OTCQB: FSDDF FRA: 0K9 TORONTO, Nov. 28, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) announced today that the Company's facility and land located ... [Read]

FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

Nov 26

Syndicated under license via QuoteMedia Management addition comes as FSD accelerates specialty cannabinoid pharmaceutical global expansion strategy - CSE: HUGE OTCQB: FSDDF FRA: 0K9 TORONTO, Nov. 26, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or "FSD") ... [Read]

FSD Pharma adds David Urban to Board of Directors

Nov 16

Syndicated under license via QuoteMedia TORONTO, Nov. 14, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) announced today the appointment of David Urban to the Company's Board of Directors. Mr. Urban is an ... [Read]